Pathogen Evolution Impacting Vaccines

The evolution of pathogens is a major challenge in the development and effectiveness of vaccines. As pathogens mutate, they may alter the antigens that trigger immune responses, potentially rendering previously developed vaccines less effective or ineffective against new strains. This is particularly evident in rapidly evolving viruses like influenza, HIV, and SARS-CoV-2. Mutations and genetic shifts in these viruses may lead to antigenic variation, meaning that the immune system may no longer recognize the pathogen in the same way. To address this issue, scientists are employing advanced techniques such as genomic surveillance and predictive modeling to track the evolution of pathogens and anticipate new variants. By understanding these evolutionary patterns, vaccine developers can design more adaptable and broad-spectrum vaccines that remain effective even as pathogens evolve, ensuring continued protection against emerging threats.

Related Sessions